Doctor accused of leak to drug maker

RSS

New York Times, January 31, 2008

The prominent diabetes expert Dr. Steven M. Haffner of the University of Texas Health Science Center in San Antonio leaked an unpublished and confidential medical journal article to GlaxoSmithKline last year, tipping the company to the imminent publication of safety questions involving the company's diabetes drug Avandia. Haffner faxed the article to the drug maker after agreeing to read it as part of the peer-review process for The New England Journal of Medicine, according to a statement by Senator Charles E. Grassley, Republican of Iowa. Besides violating The New England Journal's rules, disclosing a pending article would also be considered a breach of professional ethics.

Full Story

FDA warns J&J on illegal marketing of medical devices

Another day, another Johnson & Johnson news item -- and once again, not a flattering one. The drugmaker, which can't seem to get its act straight lately, last week received a warning...

Device makers under scrutiny in international bribery beef

The U.S. government is investigating whether medical device and pharmaceutical companies are guilty of bribing foreign officials: Doctors in foreign countries who work for their governments' healthcare...

Former hospital employees seek details of St. Vincent’s financial collapse

A coalition of former employees of St. Vincent's Hospital and Lower Manhattan community advocates said they have filed a lawsuit in Manhattan Supreme Court Monday to shed light on financial mishandling that...

go to complete list